Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. - Wikidata - awgldk - TriplyDB

Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.

Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.

http://www.wikidata.org/entity/Q34452887

about

Nanotoxicology - a pathologist's perspective Titanium dioxide nanoparticles: a review of current toxicological data Toxicology of nanomaterials used in nanomedicine Human health implications of nanomaterial exposure Dispersion method for safety research on manufactured nanomaterials Applications of nanotechnology in dermatology Nanosizing of drugs: Effect on dissolution rate Activation of neutrophils by nanoparticles Advances in aluminum hydroxide-based adjuvant research and its mechanism Development of Taiwan's strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations Toxicity of nanomaterials Molecular mechanism of DNA damage induced by titanium dioxide nanoparticles in toll-like receptor 3 or 4 expressing human hepatocarcinoma cell lines Comparison of the behaviour of manufactured and other airborne nanoparticles and the consequences for prioritising research and regulation activities Recent advances in particulate matter and nanoparticle toxicology: a review of the in vivo and in vitro studies Convergence of nanotechnology and cancer prevention: are we there yet?Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Principal component and causal analysis of structural and acute in vitro toxicity data for nanoparticles.Iron nanoparticles increase 7-ketocholesterol-induced cell death, inflammation, and oxidation on murine cardiac HL1-NB cells.Hierarchical Rank Aggregation with Applications to Nanotoxicology.In vivo effect of industrial titanium dioxide nanoparticles experimentally exposed to hairless rat skin.Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles.Nanomedicine--challenge and perspectives.Carbon nanodots interference with lactate dehydrogenase assay in human monocyte THP-1 cells Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids.Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells Nanoparticles for applications in cellular imaging.Cutaneous exposure to agglomerates of silica nanoparticles and allergen results in IgE-biased immune response and increased sensitivity to anaphylaxis in mice.Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation.Exposure to Palladium Nanoparticles Affects Serum Levels of Cytokines in Female Wistar Rats.Silica nanoparticles induce reversible damage of spermatogenic cells via RIPK1 signal pathways in C57 mice.Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.Nanoparticle-induced pulmonary toxicity.Nanotoxicology: an interdisciplinary challenge.Toxico-/biokinetics of nanomaterials.Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways.Fourier-transform infrared spectroscopy for rapid screening and live-cell monitoring: application to nanotoxicology.CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug products.Assessing nanoparticle risk poses prodigious challenges.

P2860

Q23909944-2142FCFA-24A2-4C50-991C-7C21CCC395A1 Q23913609-A04A2E78-8260-4BE9-BDD7-A62C98367F9F Q23914977-0C99CCEB-04AA-4B46-A907-572CFE7C2979 Q23922473-DECDABD3-73BC-40A8-A816-16F182D16716 Q23923626-D6022E1F-F15D-42AF-AB42-86A3B26375A6 Q24170384-E17B2926-790B-4650-892D-39CB9DAAA66A Q26781058-DBBBFA99-2ABC-4976-924E-4F8F1C1224ED Q26995680-77225A39-5161-426B-BDA9-E934A67EF530 Q27007659-343455B9-FBEA-4B06-83D6-879AEFD5350B Q27687656-4C71A72E-9061-4856-A327-B9ACBAE91732 Q28383168-621E19A3-AD0A-4A77-A07B-548C6199FE03 Q28383875-CB0E59C8-E749-4A8C-9EF4-DC2D982799ED Q28384705-33FF9561-9145-438C-9911-21959B2232F3 Q28385376-AB23D916-A1F5-4B43-82F9-836AD22DDA56 Q28386699-4666E743-083F-480E-8B88-BE76FEBCE7E3 Q29248491-585164E4-1928-48D0-81A6-3C80777E6808 Q30387307-EA41377A-8A51-4F3F-B614-5DC2DE6FFE04 Q30616632-9D304A11-26CC-45CA-B47E-F74E3957671C Q33576888-270F1D38-3304-48A6-B79B-DBF547501378 Q33621840-4D6417AD-2566-483A-8183-7C27359EF9E2 Q33675325-C6E0C785-CD7C-4967-9C21-151F3E5F887C Q33862718-DDC71EC2-CA24-4513-9728-2B26D513F472 Q34177556-92BB0DC1-09DB-4B17-923B-39446B38B3E7 Q34247073-91B1EF3E-F44C-4368-98E1-091F10947A5E Q34422373-DF0FB998-E739-46F6-9EEC-0869FF04699E Q35410974-CFAAFCD0-C5AF-4F59-ACA0-8C7DD5F151CE Q35489449-3D5ABAB5-FCB0-46F2-BEF3-4880C715E41F Q35635842-6E9279A9-D96E-478E-BC80-2CE91AC7FD24 Q35786805-D7F1EB8E-3F41-4020-99AB-C67155E18092 Q35846840-72C9AC96-8E9C-49FC-AF7A-63CE3AFB017C Q35855610-12FA4516-D7F2-4168-9653-28C6E1CE52F1 Q36951459-DC6AE4EE-B45F-4788-9FDB-6F8E351722FD Q37668353-E12091B8-C1F5-4AD2-A5FD-634C467C78DE Q37780881-A8BB3B6C-4F52-4BA1-B1A2-28DF4F93C552 Q37835204-AD9F06B5-0FA4-4284-9310-3EE9CB8CB115 Q38009230-B3972A62-55DF-4FEE-AB8E-1162BC567BB2 Q38053080-95EA62F9-9F1E-4DD3-B601-359728E0F1AF Q38068917-601D498A-4178-4D09-8CE6-CBABF8D281C6 Q38091386-BCF96562-159E-48BF-967A-303B7BF985D6 Q38097389-D325100F-30EE-464A-92D5-D06AF64F1A0F

P2860

Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.

http://www.wikidata.org/entity/Q34452887

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Research strategies for safety ...... k assessment of nanoparticles.

@ast

Research strategies for safety ...... k assessment of nanoparticles.

@en

Research strategies for safety ...... k assessment of nanoparticles.

@nl

type

label

Research strategies for safety ...... k assessment of nanoparticles.

@ast

Research strategies for safety ...... k assessment of nanoparticles.

@en

Research strategies for safety ...... k assessment of nanoparticles.

@nl

prefLabel

Research strategies for safety ...... k assessment of nanoparticles.

@ast

Research strategies for safety ...... k assessment of nanoparticles.

@en

Research strategies for safety ...... k assessment of nanoparticles.

@nl

P1433

Q34452887-6076D3CE-9AC6-4F29-B542-9D758340CAAE

P1476

Q34452887-33B535C9-33EC-4265-BB4C-216CBD5FC558

P2093

Q34452887-0307933D-0908-4BB7-B066-AF5F523BF807

Q34452887-0F01AF17-0EF7-4F60-B9F4-C00D47D786D4

Q34452887-6306153A-43B6-470C-A889-AC634A143737

Q34452887-6D6CE84D-E7FB-4C56-B01A-D7255A51EEE0

Q34452887-7AF496C5-3B48-4511-B580-779C532CBCAD

Q34452887-7C3CF132-04EC-4000-BED2-58334718270E

Q34452887-BF700781-EC7E-43ED-B52A-0CF5736A0114

P2860

Q34452887-01EBA8B3-5136-4E29-A4A2-CEF894F863A9

Q34452887-07E901FA-1D57-437E-8633-97CF48FCD6EE

Q34452887-0F4A29E7-3CCE-425A-82D9-AE4A48F0EF1D

Q34452887-11A5055F-BE1B-4E2F-99C9-E431BB292624

Q34452887-15AC0973-7E1D-4F03-B047-479B1EA3EA84

Q34452887-17C658A2-F987-4925-9387-687A8C4F3253

Q34452887-1E2DE6C0-1CDD-4A8A-89F7-5D052657948B

Q34452887-28DC61CE-EABC-48B8-99A1-52792A4EE887

Q34452887-2A86AC0E-200A-49E1-8980-CF70A0FF7610

Q34452887-2D54612A-94B9-423C-A334-25F489FCF828

P304

Q34452887-76F2B40A-72DF-440A-9AB2-7A95FA0A8E1D

P31

Q34452887-AB4A43D9-E49D-4E55-8757-5D0B5FDCCE11

P356

Q34452887-EE2FA732-06FE-4939-97B7-AC28ED5BC933

P433

Q34452887-2CB67E8D-6641-404F-9E54-13972D0B77A9

P478

Q34452887-F52D7E4E-CF85-49E4-A85D-83539D883131

P577

Q34452887-FAB49AF3-73FC-4247-A7EC-2ED2B29B06BA

P5875

Q34452887-6CC5BC7D-9957-4278-84CD-0FF6039A3419

P698

Q34452887-1DCAD654-D642-46A5-B7A4-EF3D06D460E7

P921

Q34452887-1636EEA8-C536-47E3-BD69-92AAE9A5612E

Q34452887-3FA21FD7-DFCB-4C93-9C99-2D6BC78A7FC3

P356

P1433

Toxicological Sciences

P1476

Research strategies for safety ...... k assessment of nanoparticles.

@en

P2093

Andrew D Maynard

http://www.w3.org/2001/XMLSchema#string

Annette B Santamaria

http://www.w3.org/2001/XMLSchema#string

Chiu-Wing Lam

http://www.w3.org/2001/XMLSchema#string

David B Warheit

http://www.w3.org/2001/XMLSchema#string

John T James

http://www.w3.org/2001/XMLSchema#string

Joyce S Tsuji

http://www.w3.org/2001/XMLSchema#string

Paul C Howard

http://www.w3.org/2001/XMLSchema#string

P2860

Airborne nanostructured particles and occupational health

Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material

Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells

Comparing aerosol surface-area measurements of monodisperse ultrafine silver agglomerates by mobility analysis, transmission electron microscopy and diffusion charging

Skin as a route of exposure and sensitization in chronic beryllium disease

Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles

Nanotechnology: looking as we leap

Correlation between particle size, in vivo particle persistence, and lung injury

Passage of inhaled particles into the blood circulation in humans

Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low

P304

42-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/TOXSCI/KFI339

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7587189

http://www.w3.org/2001/XMLSchema#string

P698

16177233

http://www.w3.org/2001/XMLSchema#string

P921